During systemic infecti on, inflammatory cytokines such as interleukin (IL)-6 are produced in excess in the brain of aged mice and induce severe behavioral deficits. However, no studies have examined how pro-inflammatory IL-6 tran s-signaling is involved in the exaggerated production of IL-6 in the aged brain, nor the extent to which IL-6 trans-signaling affects other markers of neuroinflammation, adhesion molecules, and behavior. Therefore, this study investigat ed in aged mice the presence of IL-6 signaling subunits in microglia; the central effects of soluble gp130 (sgp130)-a natural inhibitor of the IL-6 transsignaling pathway-on IL-6 production in microglia; and the effects of sgp130 given intracerebr oventricularly (ICV) on neuroinflammation and sickness behavior caused by i.p. injection of lipopolysaccharide (LPS). Here we show that microglia isolated from aged mice have higher expression of IL-6 receptor (IL-6R) compared to microglia from adults; and the level of mRNA for ADAM17, the enzyme responsibl e for sheddi ng membrane-bound IL-6R in trans-signaling, is higher in the hippocampus of aged mice compared to adults. Additionally, we show in aged mice that peripheral LPS challenge elicits a hyperactive IL-6 response in mic roglia, and selective blockade of trans-signaling by ICV injection of sgp130 mitigates this. The sgp130-associa ted inhibition of IL-6 was paralleled by amelioration of exaggerated and protracted sickness behavior in aged mice. Taken together, the results show that microglia are important regulators of the IL-6 trans-signaling response in the aged brain and sgp130 exerts an anti-inflammatory effect by inhibiting the pro-inflammatory arm of IL-6 signaling.
Introduction
Interleukin-6 receptor signaling is facilitated through two related pathways termed classical and trans-signaling (Rose-John, 2003) . The receptor consists of two subunits: the IL-6 receptor-alpha chain (IL-6R), which binds IL-6, and the trans-membrane signaling subunit, glycoprotei n 130 (gp130), which is the intracellul ar signal transduc er that is constitutivel y expressed. Classical activation consists of the IL-6 binding to the membran ebound IL-6R, while trans-signaling is the ability of a soluble IL-6R (sIL-6R) to bind IL-6 in the extracellul ar compartme nt to form an IL-6/sIL-6 R complex and in turn, activate gp130. On the one hand, the expression pattern of membran e-bound IL-6R is limited to cells of the immune system and sparsely dispersed among other cell types (Schobitz et al., 1993 ) . On the other hand, gp130 is ubiquitously expressed; therefore IL-6 trans-signaling confers IL-6 responsiv eness in any cell type that expresses gp130 and is exposed to the IL-6/sIL-6R complex (Jones et al., 2005; Kishimoto et al., 1992 ) . Recent studies of monocytes show that two specific members of the ADAM (a disintegrin and metallopr otease domain) family, ADAM17 and ADAM10, contribute to IL-6R shedding, which is necessar y to generate sIL-6R (Matthews et al., 2003 ) .
Although both pro-inflammatory and anti-inflammatory actions have been reported for IL-6 (Scheller et al., 2011 ) , the transsignaling pathway is pro-inflammatory and has been implicate d in several chronic inflammatory diseases including chronic inflammatory bowel disease, rheumatoi d arthritis, and colon cancer
